These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 25453804

  • 61. Flexibility of small molecular CD4 mimics as HIV entry inhibitors.
    Kobayakawa T, Ohashi N, Hirota Y, Takahashi K, Yamada Y, Narumi T, Yoshimura K, Matsushita S, Harada S, Tamamura H.
    Bioorg Med Chem; 2018 Nov 15; 26(21):5664-5671. PubMed ID: 30366786
    [Abstract] [Full Text] [Related]

  • 62. Scyllatoxin-based peptide design for E. coli expression and HIV gp120 binding.
    Nurheibah SI, Sayyed ND, Batyanovskii AV, Talwar CS, Ahn WC, Park KH, Tuzikov AV, Ha KS, Woo EJ.
    Biochem Biophys Res Commun; 2024 Oct 01; 727():150310. PubMed ID: 38941793
    [Abstract] [Full Text] [Related]

  • 63. Specific Noncovalent Interactions Determine Optimal Structure of a Buried Ligand Moiety: QM/MM and Pure QM Modeling of Complexes of the Small-Molecule CD4 Mimetics and HIV-1 gp120.
    Moraca F, Rinaldo D, Smith AB, Abrams CF.
    ChemMedChem; 2018 Mar 20; 13(6):627-633. PubMed ID: 29337418
    [Abstract] [Full Text] [Related]

  • 64. Identification of gp120 Residue His105 as a Novel Target for HIV-1 Neutralization by Small-Molecule CD4-Mimics.
    Fritschi CJ, Liang S, Mohammadi M, Anang S, Moraca F, Chen J, Madani N, Sodroski JG, Abrams CF, Hendrickson WA, Smith AB.
    ACS Med Chem Lett; 2021 Nov 11; 12(11):1824-1831. PubMed ID: 34795873
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. New brominated and halogen-less derivatives and structure-activity relationship of azaphilones inhibiting gp120-CD4 binding.
    Matsuzaki K, Tahara H, Inokoshi J, Tanaka H, Masuma R, Omura S.
    J Antibiot (Tokyo); 1998 Nov 11; 51(11):1004-11. PubMed ID: 9918393
    [Abstract] [Full Text] [Related]

  • 68. CD4 antagonists.
    McKeating JA.
    Biochem Soc Trans; 1992 May 11; 20(2):521-5. PubMed ID: 1397653
    [No Abstract] [Full Text] [Related]

  • 69. Isochromophilones I and II, novel inhibitors against gp120-CD4 binding produced by Penicillium multicolor FO-2338. II. Structure elucidation.
    Matsuzaki K, Tanaka H, Omura S.
    J Antibiot (Tokyo); 1995 Jul 11; 48(7):708-13. PubMed ID: 7649872
    [Abstract] [Full Text] [Related]

  • 70. Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry Inhibition.
    Melillo B, Liang S, Park J, Schön A, Courter JR, LaLonde JM, Wendler DJ, Princiotto AM, Seaman MS, Freire E, Sodroski J, Madani N, Hendrickson WA, Smith AB.
    ACS Med Chem Lett; 2016 Mar 10; 7(3):330-4. PubMed ID: 26985324
    [Abstract] [Full Text] [Related]

  • 71. Correction to Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.
    Curreli F, Kwon YD, Belov DS, Ramesh RR, Kurkin AV, Altieri A, Kwong PD, Debnath AK.
    J Med Chem; 2017 Jun 08; 60(11):4734. PubMed ID: 28517931
    [No Abstract] [Full Text] [Related]

  • 72. Sequence-controlled multi-block glycopolymers to inhibit DC-SIGN-gp120 binding.
    Zhang Q, Collins J, Anastasaki A, Wallis R, Mitchell DA, Becer CR, Haddleton DM.
    Angew Chem Int Ed Engl; 2013 Apr 15; 52(16):4435-9. PubMed ID: 23494988
    [No Abstract] [Full Text] [Related]

  • 73. Illuminating HIV gp120-Ligand Recognition through Computationally-Driven Optimization of Antibody-Recruiting Molecules.
    Parker CG, Dahlgren MK, Tao RN, Li DT, Douglass EF, Shoda T, Jawanda N, Spasov KA, Lee S, Zhou N, Domaoal RA, Sutton RE, Anderson KS, Jorgensen WL, Krystal M, Spiegel DA.
    Chem Sci; 2014 Jun 01; 5(6):2311-2317. PubMed ID: 25379167
    [Abstract] [Full Text] [Related]

  • 74. The chemistry and applications of RNA 2'-OH acylation.
    Velema WA, Kool ET.
    Nat Rev Chem; 2020 Jan 01; 4(1):22-37. PubMed ID: 32984545
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Advancing translational research with next-generation protein microarrays.
    Yu X, Petritis B, LaBaer J.
    Proteomics; 2016 Apr 01; 16(8):1238-50. PubMed ID: 26749402
    [Abstract] [Full Text] [Related]

  • 77. Probing of CD4 binding pocket of HIV-1 gp120 glycoprotein using unnatural phenylalanine analogues.
    Yu X, Talukder P, Bhattacharya C, Fahmi NE, Lines JA, Dedkova LM, LaBaer J, Hecht SM, Chen S.
    Bioorg Med Chem Lett; 2014 Dec 15; 24(24):5699-5703. PubMed ID: 25453804
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. The HIV-1 Env gp120 Inner Domain Shapes the Phe43 Cavity and the CD4 Binding Site.
    Prévost J, Tolbert WD, Medjahed H, Sherburn RT, Madani N, Zoubchenok D, Gendron-Lepage G, Gaffney AE, Grenier MC, Kirk S, Vergara N, Han C, Mann BT, Chénine AL, Ahmed A, Chaiken I, Kirchhoff F, Hahn BH, Haim H, Abrams CF, Smith AB, Sodroski J, Pazgier M, Finzi A.
    mBio; 2020 May 26; 11(3):. PubMed ID: 32457241
    [Abstract] [Full Text] [Related]

  • 80. Atomic insight into the CD4 binding-induced conformational changes in HIV-1 gp120.
    Hsu ST, Bonvin AM.
    Proteins; 2004 May 15; 55(3):582-93. PubMed ID: 15103622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.